PGI17 COST-EFFECTIVENESS OF TOFACTINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER CONVENTIONAL THERAPY IN SPAIN

Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.1140
https://www.valueinhealthjournal.com/article/S1098-3015(19)33518-1/fulltext
Section Title :
Section Order : 10999
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33518-1&doi=10.1016/j.jval.2019.09.1140
HEOR Topics :
Tags :
Regions :